At a glance
ClinicalIndex Comparison RecordStandardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Randomized Double-blinded Controlled Trial Comparing Dilation and Evacuation Outcomes With and Without Oxytocin Use
In Brief
A clinical study evaluating intravenous oxytocin and Intravenous Fluids and Electrolytes for Abortion and 3 related conditions. Completed, enrolled 166 participants across 2 sites.
Detailed Summary
Currently, there is very little research to identify ways to decrease blood loss during D\&E (dilation and evacuation) procedures. The objective is to determine whether routine use of intravenous oxytocin will improve bleeding outcomes at the time of D\&E at 18-24-weeks gestation. To evaluate the hypothesis, investigators will perform a randomized, double-blinded, placebo-controlled trial. The patient will be followed until discharged from the postoperative care unit during which time patient satisfaction, pain score and postoperative bleeding will be assessed.
Study Details
Timeline
Interventions
30 units of oxytocin added to 500ml of inert IV fluid (saline, lactated ringer)
500 ml of inert IV fluid